Systemic inflammation as measured by the biomarkers; C-reactive protein (CRP), leukocytes and fibrinogen is associated with a two to four-fold increased risk of comorbidities including cardiovascular disease and lung cancer [52]. The gene discussed is CRP; the disease is lung cancer.